Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
InVitae Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
InVitae Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 8
InVitae Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
InVitae Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 10
InVitae Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
InVitae Corp, Medical Equipment, Deal Details 13
Venture Financing 13
InVitae Raises USD16 Million in Venture Financing 13
InVitae Raises USD120 Million in Series F Venture Financing 14
Invitae Raises US$40 Million In Series E Financing 16
Good Start Genetics Raises US$14 Million In Initial Closing Of Series B Financing 18
Partnerships 19
CombiMatrix Enters Into Licensing Agreement With Cartagenia For Benchlab CNV Platform 19
Invitae and KEW Enter into Partnership 20
Invitae Enters into Clinical Research Agreement with TME Research 21
Good Start Genetics Enters into Marketing Agreement with Roche Diagnostics 22
CombiMatrix Enters into Distribution Agreement with Universal Diagnostic Labs 23
Good Start Genetics Enters into Agreement with IviGen and iGenomix 24
Good Start Genetics Enters Into Agreement With PerkinElmer To Provide GoodStart Select Carrier Screening Tests 25
Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing 26
CombiMatrix Expands Co-Marketing Agreement With Pathology For Prenatal Tests 27
CombiMatrix Enters Into Co-Marketing Agreement With Pathology For Prenatal Tests 28
Good Start Genetics Enters into Licensing Agreement with Johns Hopkins University 29
Equity Offering 30
Invitae Prices Public Offering of Shares for USD50 Million 30
Invitae to Raise Funds through Public Offering of Shares 32
Invitae to Raise Funds through Public Offering of Shares 33
Invitae Raises USD73.5 Million in Private Placement of Shares and Preferred Shares 34
Invitae Raises USD50.6 Million in Public Offering of Shares 35
CombiMatrix Raises USD8 Million in Public Offering of Units 37
CombiMatrix Raises USD3.34 Million in Private Placement of Warrants 39
Invitae Raises USD117 Million in IPO 41
CombiMatrix Raise USD5 Million in Private Placement of Securities 43
CombiMatrix Completes Public Offering Of Units For US$12 Million 45
CombiMatrix Completes Second Tranche Of Private Placement Of Preferred Shares For US$1.2 Million 46
CombiMatrix Completes Private Placement Of Common Stock For US$0.4 Million 47
CombiMatrix Completes Private Placement Of Units For US$1.6 Million 48
CombiMatrix Completes Second Tranche Of Private Placement Of Series A Shares Of Preferred Stock 49
Acquisition 50
Invitae Acquires CombiMatrix for USD35 Million 50
Invitae to Acquire Good Start Genetics 52
Invitae Acquires AltaVoice 53
InVitae Corp – Key Competitors 54
InVitae Corp – Key Employees 55
InVitae Corp – Locations And Subsidiaries 56
Head Office 56
Other Locations & Subsidiaries 56
Recent Developments 57
Financial Announcements 57
Aug 07, 2018: Invitae reports more than 160% annual revenue growth driven by nearly 140% annual growth in volume in second quarter 2018 57
May 09, 2018: Invitae Reports 169% Revenue Growth Driven by 150% Growth in Volume in First Quarter 2018 58
Feb 12, 2018: Invitae reports over 150% volume and over 170% revenue growth for 2017 60
Jan 08, 2018: Invitae more than doubles annual volume, exceeds full-year 2017 guidance, and projects momentum to continue in 2018 62
Nov 06, 2017: Invitae Reports Double-Digit Sequential Volume and Revenue Growth in Third Quarter 2017 63
Aug 07, 2017: Invitae Reports Second Quarter 2017 Results 66
May 08, 2017: Invitae Exceeds 26,000 Samples Accessioned, Reports Revenue of $10.3 Million and Net Loss of $0.64 Per Share in First Quarter 2017 68
Mar 16, 2017: Oxford Finance Signs Loan and Security Agreement With Invitae 70
Feb 13, 2017: Invitae reports revenue of $9.2 million in fourth quarter 2016 and projects strong volume and revenue growth in 2017 71
Jan 06, 2017: Invitae meets annual volume guidance, projects doubling of volume in 2017, accelerates Genome Network by acquiring scalable patient-centered data company 73
Corporate Communications 74
Sep 11, 2018: Invitae names Chitra Nayak to its Board of Directors 74
May 25, 2017: Invitae Broadens Management Team to Scale Expanding Business and Meet Rising Demand 75
Mar 16, 2017: Oxford Finance Signs Loan and Security Agreement With Invitae 76
Jan 09, 2017: Invitae announces new leadership structure to drive global growth 77
Government and Public Interest 78
Jun 05, 2017: ASCO Data Shows Prostate Cancer Patients with Genetic Risk Factors Missed Under Current Testing Guidelines 78
Product News 79
Apr 10, 2018: Invitae research highlights utility of proactive genetic screening, importance of assessing secondary findings in genetic testing 79
Dec 05, 2017: Invitae to present findings at 2017 San Antonio Breast Cancer Symposium 82
Dec 05, 2017: Multigene Genetic Testing Improves Identification and Management of Hereditary Cancer Risk for Breast Cancer Patients and Their Families 83
Oct 30, 2017: Invitae Presents Validation of a Novel NGS-based Preimplantation Genetic Screening Technology to Identify the Most Frequent Chromosomal Causes of Miscarriage 84
Apr 28, 2017: New research suggests current genetic testing guidelines may miss breast cancer patients who could benefit from testing 86
Apr 20, 2017: Invitae announces expansion of its genetic test menu with addition of new tests and expanded panels for inherited metabolic and immune system disorders, including panels to confirm diagnoses suggested by newborn screening 88
Feb 17, 2017: New research suggests broader genetic testing of prostate cancer patients may be warranted to identify risk of an inherited mutation that might inform treatment 89
Other Significant Developments 91
Jun 13, 2018: Invitae Study of 143,000 Patients Shows Importance of Routinely Including Deletion and Duplication Detection with Sequencing in Genetic Testing 91
May 07, 2018: Genome Medical Enters Employer Market with Diverse Genetic Health Programs and Wave of New Partners 92
Feb 27, 2018: Invitae expands existing credit facility to provide up to $40.0 million in available growth capital 93
Oct 05, 2017: Invitae’s new framework for classifying genetic variants aims to improve consistency of genetic test results industry-wide 94
Mar 30, 2017: Invitae announces introduction of exome testing 95
Mar 23, 2017: Invitae Expands Test Menu for Proactive Genetic Testing in Healthy Adults 96
Appendix 97
Methodology 97
About GlobalData 97
Contact Us 97
Disclaimer 97
InVitae Corp, Medical Equipment, Key Facts, 2017 2
InVitae Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
InVitae Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
InVitae Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 8
InVitae Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
InVitae Corp, Deals By Market, 2012 to YTD 2018 10
InVitae Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
InVitae Raises USD16 Million in Venture Financing 13
InVitae Raises USD120 Million in Series F Venture Financing 14
Invitae Raises US$40 Million In Series E Financing 16
Good Start Genetics Raises US$14 Million In Initial Closing Of Series B Financing 18
CombiMatrix Enters Into Licensing Agreement With Cartagenia For Benchlab CNV Platform 19
Invitae and KEW Enter into Partnership 20
Invitae Enters into Clinical Research Agreement with TME Research 21
Good Start Genetics Enters into Marketing Agreement with Roche Diagnostics 22
CombiMatrix Enters into Distribution Agreement with Universal Diagnostic Labs 23
Good Start Genetics Enters into Agreement with IviGen and iGenomix 24
Good Start Genetics Enters Into Agreement With PerkinElmer To Provide GoodStart Select Carrier Screening Tests 25
Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing 26
CombiMatrix Expands Co-Marketing Agreement With Pathology For Prenatal Tests 27
CombiMatrix Enters Into Co-Marketing Agreement With Pathology For Prenatal Tests 28
Good Start Genetics Enters into Licensing Agreement with Johns Hopkins University 29
Invitae Prices Public Offering of Shares for USD50 Million 30
Invitae to Raise Funds through Public Offering of Shares 32
Invitae to Raise Funds through Public Offering of Shares 33
Invitae Raises USD73.5 Million in Private Placement of Shares and Preferred Shares 34
Invitae Raises USD50.6 Million in Public Offering of Shares 35
CombiMatrix Raises USD8 Million in Public Offering of Units 37
CombiMatrix Raises USD3.34 Million in Private Placement of Warrants 39
Invitae Raises USD117 Million in IPO 41
CombiMatrix Raise USD5 Million in Private Placement of Securities 43
CombiMatrix Completes Public Offering Of Units For US$12 Million 45
CombiMatrix Completes Second Tranche Of Private Placement Of Preferred Shares For US$1.2 Million 46
CombiMatrix Completes Private Placement Of Common Stock For US$0.4 Million 47
CombiMatrix Completes Private Placement Of Units For US$1.6 Million 48
CombiMatrix Completes Second Tranche Of Private Placement Of Series A Shares Of Preferred Stock 49
Invitae Acquires CombiMatrix for USD35 Million 50
Invitae to Acquire Good Start Genetics 52
Invitae Acquires AltaVoice 53
InVitae Corp, Key Competitors 54
InVitae Corp, Key Employees 55
InVitae Corp, Subsidiaries 56
List of Figures
InVitae Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
InVitae Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
InVitae Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
InVitae Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
InVitae Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
InVitae Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 8
InVitae Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
InVitae Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 10
